Case-Based Exchanges

This “Case-Based Exchange” concludes our 3-part series, featuring discussions on 2 early breast cancer patient cases. Joyce O’Shaughnessy, MD, and Marissa Marti-Smith, DNP, APRN, AGNP-C, AOCNPO, share their perspectives on practical, patient-focused strategies for optimal management of abemaciclib-related side effects.

This “Case-Based Exchange” concludes our 3-part series, featuring discussions on 2 early breast cancer patient cases. Joyce O’Shaughnessy, MD, and Marissa Marti-Smith, DNP, APRN, AGNP-C, AOCNPO, share their perspectives on practical, patient-focused strategies for optimal management of abemaciclib-related side effects.

In this second segment of our 3-part “Case-Based Exchange” series, Joyce O’Shaughnessy, MD, and Marissa Marti-Smith, DNP, APRN, AGNP-C, AOCNPO, discuss 2 patient cases with early breast cancer, outlining methods for fostering active engagement and collaborative conversations with patients and caregivers about the incorporation of abemaciclib into treatment plans.

In this second segment of our 3-part “Case-Based Exchange” series, Joyce O’Shaughnessy, MD, and Marissa Marti-Smith, DNP, APRN, AGNP-C, AOCNPO, discuss 2 patient cases with early breast cancer, outlining methods for fostering active engagement and collaborative conversations with patients and caregivers about the incorporation of abemaciclib into treatment plans.

In the first set of videos of this series, Joyce O’Shaughnessy, MD, and Marissa Marti-Smith, DNP, APRN, AGNP-C, AOCNPO, explore complementary approaches to identifying patients with breast cancer who have specific characteristics associated with a high risk of recurrence. Together, these perspectives underscore the multifaceted approach needed for effective risk assessment in early-stage breast cancer.

In the first set of videos of this series, Joyce O’Shaughnessy, MD, and Marissa Marti-Smith, DNP, APRN, AGNP-C, AOCNPO, explore complementary approaches to identifying patients with breast cancer who have specific characteristics associated with a high risk of recurrence. Together, these perspectives underscore the multifaceted approach needed for effective risk assessment in early-stage breast cancer.

This case-based exchange features Tajuana Bradley, MS, FNP-C, and Ryan Haumschild, PharmD, MS, MBA, CPEL, discussing their best practices for a patient with metastatic breast cancer treated with antibody-drug conjugate therapy.